SCG3 and Parkinson disease: In Parkinson’s Disease (PD) research, SCG3 is upregulated in astrocytes exposed to Parkinsonian toxins such as MPTP (1-methyl-1.2.3.6.-tetrahydropyridine), a major synthetic neurotoxin, suggesting its involvement in astrocyte activation and neuroinflammatory process43.